Back to All Events

TIME IS MUSCLE. ACUTE INTERVENTION TRIALS IN CORONARY ARTERY DISEASE AND IN HEART FAILURE

Chairpersons: Roxana Mehran (New York, USA), Alexandre Mebazaa (Paris, FRA)
2.00 pm – 6.30 pm
1. Advances and remaining gaps in the early management of acute coronary
syndromes
· How early is early? Chest pain characteristics and opportunities for very
early management from contemporary databases.
Speaker : Patrick Badertscher (Basel, CHE)
Discussant : Justin Ezekowitz (Alberta, CAN)
· Pre hospital, pre PCI intervention. Review of the evidence: Did ATLANTIC
and ACCOAST really fail?
Roxana Mehran (New York, USA)
· How different is a STEMI from a NSTEMI in their infancy?
Wolfgang Koenig (Munich, GER)
· 10-year trends in time to reperfusion of STEMI patients in France
Tabassome Simon (Paris, FRA)
· Home based detection of cardiac ischemia
Olivier Chételat (Neuchâtel, CHE)
· Industry viewpoint:
Sébastien Roux (Idorsia, CHE)
· Regulatory viewpoint
Ellis Unger (FDA, USA)
2. Advances and remaining gaps in the early management of heart failure
· Early pre-admission diagnosis and management of HF congestion related
dyspnea.
Nicolas Girerd (Nancy, FRA)
· Early therapy in AHF. Rearview and ways forward. How to progress from
proof of concept to outcome trials.
Alexandre Mebazaa (Paris, FRA)
· Diuretic – decongesting strategies trials
Eric J. Velazquez (Durham, USA)

· Industry viewpoint
Shalabh Singhal (BMS, USA)
· Regulatory viewpoint
Robert Temple (FDA, USA)
Patient education : Community intervention (campaign) vs. targeted education of
patients
Holli DeVon (Chicago, USA)
Patient viewpoint : Annemieke Lenselink (The Hague Area, NED); Natascha Van der
Post (Nijmegen Area, NED)
THE FORUM
Moderated discussion with the audience
Chairpersons: Roxana Mehran (New York, USA), Alexandre Mebazaa (Paris, FRA)
Panelists: Patrick Badertscher (Basel, CHE), Olivier Chételat (Neuchâtel, CHE), Holli
DeVon (Chicago, USA), Justin Ezekowitz (Alberta, CAN), Nicolas Girerd (Nancy, FRA),
Wolfgang Koenig (Munich, GER), Annemieke Lenselink (The Hague Area, NED);
Alexandre Mebazaa (Paris, FRA), Roxana Mehran (New York, USA), Sébastien Roux
(Idorsia, CHE), Tabassome Simon (Paris, FRA), Shalabh Singhal (BMS, USA), Robert
Temple (FDA, USA), Ellis Unger (FDA, USA), Natascha Van der Post (Nijmegen Area,
NED), Eric J. Velazquez (Durham, USA)